TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against TransMedics Group, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements regarding its business practices and safety issues [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to securities purchased between February 28, 2023, and January 10, 2025, and investors are encouraged to contact the Schall Law Firm before April 15, 2025, to participate [2]. - The complaint alleges that TransMedics generated revenue through kickbacks, overbilling, and coercive tactics, while concealing safety issues and engaging in unsafe practices [4]. Group 2: Investor Representation - The class in this case has not yet been certified, meaning that until certification occurs, investors are not represented by an attorney [3]. - Investors who suffered losses are invited to join the case to recover their damages [4]. Group 3: Law Firm Information - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally [5]. - Contact information for the Schall Law Firm is provided for investors seeking to discuss their rights [6].